Castaneda R, Sussman N, Levy R, O'Malley M, Westreich L
Department of Psychiatry, New York University School of Medicine, Bellevue Hospital Medical Center, New York 10016, USA.
Recent Dev Alcohol. 1998;14:197-226. doi: 10.1007/0-306-47148-5_9.
In this chapter we discuss the effects of moderate ethanol consumption on the treatment of psychiatric and sleep disorders. A review of the literature on the interactions of ethanol with neurotransmitters and psychotropic medications suggests that although ethanol affects the clinical course of psychiatric and sleep disorders by different mechanisms, it does so principally through perturbations it causes in the balance of central nervous system neurotransmitter systems, which may modify the clinical course of primary psychiatric and sleep disorders and undermine the therapeutic response to psychotropic medications. Neurotransmitter responses may also be manifested clinically by rebound phenomena, akin to a subsyndromal withdrawal, which affect sleep and precipitate anxiety and mood symptoms. In addition, ethanol also modifies the clearance and disposition of a variety of psychotropic metabolites and interferes with their clinical effectiveness. We recommend that most psychiatric patients, and all patients with sleep disorders, should abstain from even moderate ethanol use, as this may adversely affect their clinical course and response to treatment.
在本章中,我们将讨论适度饮酒对精神疾病和睡眠障碍治疗的影响。对酒精与神经递质及精神药物相互作用的文献综述表明,尽管酒精通过不同机制影响精神疾病和睡眠障碍的临床病程,但其主要是通过扰乱中枢神经系统神经递质系统的平衡来实现的,这可能会改变原发性精神疾病和睡眠障碍的临床病程,并削弱对精神药物的治疗反应。神经递质反应在临床上也可能表现为类似亚综合征戒断的反弹现象,这会影响睡眠并引发焦虑和情绪症状。此外,酒精还会改变多种精神药物代谢物的清除和处置,并干扰其临床疗效。我们建议,大多数精神疾病患者以及所有睡眠障碍患者,即使适度饮酒也应戒除,因为这可能会对他们的临床病程和治疗反应产生不利影响。